This review article discusses the use of bioidentical hormone therapy (BHT) for managing menopausal symptoms and its application in dermatology. BHT, designed to mimic natural hormones, is widely marketed for its potential skin benefits, such as anti-aging effects. However, there is limited scientific evidence supporting these claims, and dermatologists are
The Endocrine Society’s statement cautions against the use of compounded bioidentical hormone therapy (cBHT), citing the lack of regulation and evidence supporting its safety and efficacy. They advise endocrinologists to prioritize FDA-approved hormone treatments instead. This review emphasizes the potential risks of unregulated therapies and urges practitioners to prioritize safety.
This article explores the widespread use of compounded bioidentical hormone therapy (cBHT), highlighting the lack of rigorous scientific evidence supporting its safety and efficacy. It stresses the need for clinicians to guide patients toward FDA-approved treatments for menopausal symptoms rather than relying on unregulated compounded alternatives. The article emphasizes the
